Document is current
Any future updates will be listed below
-
Authors
Gadi, Deepti
Martindale, Stephen P.
Chiu, Pui Yan
Khalsa, Jasneet
Chen, Pei-Hsuan
Fernandes, Stacey M.
Wang, Zixu
Tyekucheva, Svitlana
Machado, John-Hanson https://orcid.org/0000-0003-0477-3476
Fisher, David C.
Armand, Philippe https://orcid.org/0000-0001-6098-1603
Davids, Matthew S. https://orcid.org/0000-0003-4529-2003
Rodig, Scott
Sherry, Barbara https://orcid.org/0000-0003-3119-1463
Brown, Jennifer R. https://orcid.org/0000-0003-2040-4961
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (NIH/NCI R01 CA238523, NIH RO1 CA 213442)
American Society of Hematology (ASH Bridge Funding)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
- License Information
-
More Information
Article History
Received: 26 August 2022
Revised: 29 December 2022
Accepted: 9 January 2023
First Online: 2 February 2023
Competing interests
: PA has served as a consultant for Merck, BMS, ADC Therapeutics, Tessa, GenMab, C4, Enterome, Regeneron, Epizyme, Astra Zeneca, Genentech, Xencor; received research funding (inst) from Merck, BMS, Adaptive, Genentech, IGM, Kite; and received honoraria from Merck. MSD reports receiving grant support, paid to his institution, and consulting fees from Ascentage Pharma, Astra-Zeneca, BMS, Genentech, MEI Pharma, Pharmacyclics, TG Therapeutics, and Verastem, grant support, paid to his institution from Surface Oncology, and consulting fees from AbbVie, Adaptive Biotechnologies, Aptitude Health, BeiGene, Celgene, Eli Lilly, Janssen, Merck, Research to Practice, and Takeda. JRB has served as a consultant for Abbvie, Acerta/Astra-Zeneca, BeiGene, Bristol-Myers Squibb/Juno/Celgene, Catapult, Eli Lilly, Genentech/Roche, Hutchmed, Janssen, MEI Pharma, Morphosys AG, Novartis, Pfizer, Pharmacyclics, Rigel; and received research funding from BeiGene, Gilead, Loxo/Lilly, SecuraBio, Sun, TG Therapeutics. All other authors have no conflicts to disclose.
